You can buy or sell OncoSec and other stocks, options, ETFs, and crypto commission-free!
OncoSec Medical Incorporated Common Stock, also called OncoSec, is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. Read More The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
PR NewswireMar 13
OncoSec to Present at the 31st Annual ROTH Conference
SAN DIEGO and PENNINGTON, N.J., March 13, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that management will present in the 31st Annual ROTH Conference taking place March 17-19, 2019 in Dana Point, CA. The Company's presentation is via webinar and available at http://wsw.com/webcast/roth33/oncs/. About OncoSec Medical Incorporated OncoSec is a clinical-stage biotechnology company focused on developing ...
Expected Jun 13, After Hours